The “Covid Crisis” has raised many questions not only about government readiness for a global pandemic but also about the medical industry itself. The onset of the COVID pandemic pushed for a rush to find a vaccine for the disease. Then once vaccines were found, the rush was to get the population vaccinated without questioning the serum’s efficacy or safety. A recent study in Denmark found people vaccinated with Moderna may have a higher rate of heart inflammation. Don’t standard good clinical practices coupled with safety best practices apply with products such as these? Presently, the Moderna vaccine is on hold for anyone under 30 in Denmark as reported by TrialSite. Other Scandinavia nations have followed with halts for younger people.
A Danish study published in the British Medical Journal (BMJ) reports that both the Pfizer and Moderna vaccines are an effective treatment against coronavirus however the data from the study “suggests an association between SARS-CoV-2 vaccination and myocarditis and myopericarditis.” In other words, the vaccine may cause inflammation of the heart. One of the authors of the study, Anders Hviid, said the study’s findings do not generally “overshadow” the benefits of being vaccinated.
However the unreported, ultra-low absolute risk reductions of the vaccines could also suggest next to no benefits. If not that effective based on this alternative yet appropriate analysis one could argue that this could change the whole risk-benefits analysis which implicates that ineffective and potentially harmful medications or vaccines are pushed on to the public.
Close to 5 million Danes ages 12 and older participated in the study. The research took approximately one year from October of 2020 to October of 2021. Over three million of the participants were vaccinated with Pfizer and close to five hundred thousand were vaccinated with Moderna. Following the vaccination, the study found that 48 (.0014%) people who took the Pfizer shot developed myocarditis within 28 days of receiving the vaccine. From this data, it can be seen that those who are vaccinated 1.34 times as likely to develop myocarditis 28 days following vaccination than those who are unvaccinated. Of the over 490 thousand participants who received the Moderna shot 21 (.003%) people developed myocarditis within 28 days of getting the shot. The highest risk seemed to be for people between the age of 12-39 and occurred after the second dose was administered. In the 28 days following vaccination, the hazard rate of developing myocarditis in the vaccinated was almost 4 times that of the unvaccinated.
Subscribe to the Trialsitenews "COVID-19" Channel
No spam - we promise
The study also showed that after adjusting the hazard rate of developing myocarditis 28 days post-vaccination for women only, women who were vaccinated with Pfizer were almost 4x as likely to develop myocarditis compared to women who were not vaccinated, but the absolute number remains low. When doing this for men who received Pfizer, there was not a statistically significant association between the hazard rate for vaccinated men vs unvaccinated men. There were statistically significant increases in hazard rates for both men and women given Moderna, while the absolute numbers remain low.
From the study, it’s clear that there is overall a statistically significant increase in the hazard rate of myocarditis for both vaccines 28 days after vaccination, however, this is mostly driven by the rate in 12-39-year-olds following Moderna. (Adjusted hazard ratio among 12-39-year-olds in Pfizer vs Moderna: 1.48 and 5.24). However, the absolute numbers remain small, and the authors note that the overall risk of not getting vaccinated for COVID-19 compared to getting vaccinated should be carefully considered.
The authors of the study were quick to point out the prevalence of side effects was low and when they did occur, people had “predominantly mild” experiences. The authors also said the unvaccinated carried a “greater health risk” of cardiac arrest and death as a result of contracting covid. One of the authors Anders Husby said the research “supports the overall benefits of such vaccination on an individual, societal, and global level.”
TrialSite News has published many articles on Pfizer and their “lack of transparency” regarding the possible safety impacts their vaccine may have upon the vaccinated population. According to one recent TrialSite article based on the information disclosed in a FOIA, over 1200 people have died after taking the Pfizer shot and women were 3 times more likely to suffer “adverse events” as a result of the Pfizer vaccine. Of course, this doesn’t mean that the vaccine caused the deaths but many of the mortality incidents were uncomfortably close to the vaccine administration. This somewhat coincides with the study conducted in Denmark. While there is no doubt COVID rushed the world into crisis, could the “rushed” vaccine solution lead to a bigger problem in the future?